EurekAlert! - National Institutes of Health

Showing releases 226-250 out of 614 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 ]

Public Release: 25-Sep-2009
NIH fellowship recipient to study disease ecology
Camille Harris of Ridgeland, Mississippi, a graduate student in biological sciences at Virginia Tech, has been awarded a National Institutes of Health Graduate Research Fellowship for her study of forest disturbance and its ecological impacts on LaCrosse virus, a mosquito-borne disease that can cause seizures, coma, paralysis, and permanent brain damage in severe cases.

NIH/National Institute of Allergy and Infectious Disease

Public Release: 25-Sep-2009

Diabetologia
Insulin boost restores muscle growth in elderly
Researchers have demonstrated that by increasing insulin levels above the normal range in elderly test subjects, they can restore the impaired muscle-building process responsible for age-related physical weakness.

UTMB Claude Pepper Older Americans Independence Center, NIH/National Institute on Aging

Public Release: 25-Sep-2009

Chemistry & Biology
Mechanism for potential Friedreich's ataxia drug uncovered
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans. The findings, developed in collaboration with scientists from Repligen Corporation, help advance this treatment approach one step closer toward human clinical trials, which will be a welcome event for disease sufferers who currently have few treatment options.

NIH/National Institute of Neurological Disorders and Stroke, Friedreich's Ataxia Research Alliance, GoFAR, Ataxia UK, Repligen Corporation

Public Release: 25-Sep-2009

Journal of Acquired Immune Deficiency Syndromes
Certain cancers more common among HIV patients than non-HIV patients
Researchers at UT Southwestern Medical Center have found that non-AIDS-defining malignancies such as anal and lung cancer have become more prevalent among HIV-infected patients than non-HIV patients since the introduction of antiretroviral therapies in the mid-1990s.

NIH/National Institute on Alcohol Abuse and Alcoholism, US Veterans Health Administration

Public Release: 24-Sep-2009

Journal of Health and Social Behavior
Use of statins favors the wealthy, creating new social disparities in cholesterol
Since the introduction of statins to treat high cholesterol, the decline in lipid levels experienced by the wealthy has been double that experienced by the poor. Statin use may have contributed to expanding social disparities in the treatment of cardiovascular disease, according to new research by Virginia W. Chang, M.D., Ph.D., of the Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania, and Diane S. Lauderdale, Ph.D., of the University of Chicago.

NIH/National Institute of Child Health and Human Development

Public Release: 24-Sep-2009
Weill Cornell Institute for Geriatric Psychiatry awarded $10 million grant
The Weill Cornell Institute of Geriatric Psychiatry at NewYork-Presbyterian Hospital/Westchester Division announced today it has received the largest grant in its 20-year history. One of a handful awarded nationally, the new $10 million, five-year "Center Grant" from the National Institute of Mental Health will enable NewYork-Presbyterian/Weill Cornell investigators to advance their pioneering work in understanding the biological, medical, cognitive and psychosocial problems of depressed seniors.

NIH/National Institute of Mental Health

Public Release: 24-Sep-2009
University Hospitals Case Medical Center to test gammaglobulin treatment for Alzheimer's disease
Researchers from the Memory and Cognition Center at University Hospitals Case Medical Center will begin testing an intriguing new approach to slowing down the progression of Alzheimer's disease (AD) using Intravenous Immune Globulin (IGIV), also known as gammaglobulin. IGIV is traditionally used to treat primary immunodeficiency disorders, but is not currently approved for treating AD, which is one of the leading causes of dementia in the elderly.

NIH/National Institute on Aging

Public Release: 24-Sep-2009
Children who are spanked have lower IQs, new research finds
Children who are spanked have lower IQs worldwide, including in the United States, according to new groundbreaking research by University of New Hampshire professor Murray Straus. The research results will be presented Friday, Sept. 25, 2009, at the 14th International Conference on Violence, Abuse and Trauma, in San Diego, Calif.

NIH/National Institute of Mental Health, University of New Hampshire

Public Release: 24-Sep-2009

American Heart Association's 63rd High Blood Pressure Research Conference

Hypertension: Journal of the American Heart Association
Vitamin D deficiency in younger women is associated with increased risk of high blood pressure
Women who have vitamin D deficiency in the premenopausal years are at three times increased risk of developing high blood pressure in mid-life. Hypertension rose from 6 percent to 25 percent over 15 years in this study population of women average age 38.

NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases

Public Release: 22-Sep-2009

Journal of Moral Education
'Lies my parents told me'
Parents say that honesty is the best policy, but they regularly lie to their children as a way of influencing their behavior and emotions, finds new research from the University of Toronto and the University of California, San Diego.

NIH/National Institute of Child Health and Human Development

Public Release: 22-Sep-2009

General Hospital Psychiatry
New links among alcohol abuse, depression, obesity in young women found
There is new evidence that depression, obesity and alcohol abuse or dependency are interrelated conditions among young adult women but not men.

NIH/National Institute on Drug Abuse, NIH/National Institute of Mental Health

Public Release: 22-Sep-2009
Historic gene therapy trial to treat Alzheimer's disease underway at Georgetown
Researchers in the Memory Disorders Program at Georgetown University Medical Center are now recruiting volunteers for a national gene therapy trial -- the first study of its kind for the treatment of patients with dementia due to Alzheimer's disease.

NIH/National Institute on Aging, Ceregene Inc.

Public Release: 22-Sep-2009

Journal of Moral Education
Lies my parents told me
Parents say that honesty is the best policy, but they regularly lie to their children as a way of influencing their behavior and emotions, finds new research from the University of Toronto and the University of California, San Diego.

NIH/National Institute of Child Health and Human Development

Public Release: 21-Sep-2009
Can an over-the-counter vitamin-like substance slow the progression of Parkinson's disease?
Rush University Medical Center is participating in a large-scale, multi-center clinical trial in the US and Canada to determine whether a vitamin-like substance called coenzyme Q10, in high doses, can slow the progression of Parkinson's disease.

NIH/National Institute of Neurological and Disorders and Stroke

Public Release: 21-Sep-2009

Brain, Behavior and Immunity
Short-term stress enhances anti-tumor activity in mice, Stanford study shows
Researchers at the Stanford University School of Medicine have shown that, at least in laboratory mice, bouts of relatively short-term stress can boost the immune system and protect against one type of cancer. Furthermore, the beneficial effects of this occasional angst seem to last for weeks after the stressful situation has ended. The finding is surprising because chronic stress has the opposite effect -- taxing the immune system and increasing susceptibility to disease.

NIH/National Cancer Institute

Public Release: 21-Sep-2009
K-State biologist to further study of cellular process that plays role in chronic disease
A Kansas State University biologist is collaborating with the Harvard Medical School to create a clearer picture of a certain cellular process that can play a role in chronic diseases like cancer.

NIH/National Institute of General Medical Sciences

Public Release: 21-Sep-2009
'Evolutionary forecasting' for drug resistance
Rice University biochemists are developing a system of "evolutionary forecasting" that's designed to help improve antibiotic regimens for patients. In a four-year, $1 million program, the Rice team will map the molecular pathways that bacteria take to become drug-resistant. By studying how specific mutations confer resistance, Rice's team hopes to improve our ability to predict the rise of drug-resistant bacteria and stay one move ahead of them.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-Sep-2009

Experimental Hematology
Experimental drug lets B cells live and lymphoma cells die
An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology.

NIH/National Cancer Institute

Public Release: 21-Sep-2009

Proceedings of the National Academy of Sciences
Adolescent alcohol expsoure may lead to long-term risky decision making
Exposure to alcohol during adolescence apparently leads to long-term risky decision making and a new study with rats shows there is a causal link.

NIH/National Institute on Drug Abuse, NIH/National Institute on Alcohol and Alcoholism

Public Release: 21-Sep-2009

Journal of Clinical Investigation
Healing badly damaged lungs: Distinct set of white blood cells found to set the pace of wound repair
After more than 50 experiments in mice, medical scientists at Johns Hopkins have mapped out the basic steps taken by a particular set of white blood cells in setting the pace of recovery after serious lung injury.

NIH/National Heart, Lung and Blood Institute

Public Release: 21-Sep-2009

Proceedings of the National Academy of Sciences
Researchers identify gene variant linked to glaucoma
An international team, led by researchers from the University of California, San Diego, School of Medicine and the National Eye Institute, has discovered gene variants for glaucoma in a black population. The finding could lead to future treatments or a cure for this disease, which leads to blindness in 2 million Americans each year.

NIH/National Eye Institute, Research to Prevent Blindness, Burroughs Wellcome Fund

Public Release: 21-Sep-2009

Circulation: Journal of the American Heart Association
Heart attack rates drop after smoking bans, continue downward over time
Smoking bans in the United States, Europe and Canada reduce secondhand smoke-related heart attack rates in the community. The reduction in heart attacks from secondhand smoke after smoking bans are passed is consistent with estimates of individual heart attack risk from exposure to secondhand smoke. Heart attack rates continue to decrease over time, up to three years after smoking bans are enacted.

NIH/National Cancer Institute

Public Release: 21-Sep-2009

Journal of Clinical Investigation
Immune response to spinal cord injury may worsen damage
After spinal cord injury, B lymphocytes collect in the spinal fluid and release high levels of antibodies. This Ohio State University study shows that those antibodies can worsen and extend spinal cord damage. The findings suggest that inhibiting B lymphocytes may improve healing and reduce long-term effects of spinal cord injury. They may also help explain why the central nervous system does not repair itself efficiently and why other impairments often follow spinal cord injury.

NIH/National Institute of Neurological Disorders and Stroke

Public Release: 20-Sep-2009

Nature Neuroscience
UCLA scientists make paralyzed rats walk again after spinal-cord injury
UCLA researchers found that drugs, electrical stimulation and regular exercise can enable paralyzed rats to walk and even run again. The finding may hold implications for human rehabilitation after spinal cord injuries.

Christopher and Dana Reeve Foundation, Craig Nielsen Foundation, NIH/National Institute of Neurological Disorders and Stroke, US Civilian Research and Development Foundation, International Paraplegic Foundation, Swiss National Science Foundation

Public Release: 18-Sep-2009

Alcoholism: Clinical & Experimental Research
Young age at first drink may affect genes and risk for alcoholism
The age at which a person takes a first drink may influence genes linked to alcoholism, making the youngest drinkers the most susceptible to severe problems.

NIH/National Institute on Alcohol Abuse and Alcoholism, ABMRF/Foundation for Alcohol Research

Showing releases 226-250 out of 614 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 ]